Skip to main content
. Author manuscript; available in PMC: 2009 Nov 30.
Published in final edited form as: Circulation. 2006 Nov 14;114(23):2449–2457. doi: 10.1161/CIRCULATIONAHA.106.669432

Table 1.

Baseline Clinical Characteristics

Variable PCI (n=195) MED (n=186)
Mean age (range), y 57.3 (34–80) 57.8 (33–81)
Female, n (%) 33 (16.9) 33 (17.7)
Race, n (%)
 White 160 (82.1)  151 (81.2) 
 Black 6 (3.1) 5 (2.7)
 Other 29 (14.9) 30 (16.1)
No. (%) with history of:
 Diabetes* 32 (16.4) 47 (25.3)
 Hypertension 89 (45.6) 92 (49.5)
 Hyperlipidemia 108 (55.4)  111 (59.7) 
 Prior MI 25 (12.8) 17 (9.1)
 Cerebrovascular disease 11 (5.6)  1 (0.5)
 PVD  5 (2.6)  3 (1.6)
 CHF  4 (2.1)  3 (1.6)
 Prior PCI  8 (4.1)  4 (2.2)
Current smoker, n (%) 66 (33.8) 65 (34.9)
NYHA class at randomization, n (%)
 Class I 182 (93.3) 170 (91.4)
 Class II 13 (6.7) 16 (8.6)
 Class III or IV  0  0
Body mass index, mean±SD  27.5±4.2  (n=195)  28.8±5.1  (n=186)
Heart rate, bpm, mean±SD    69.2±12.2 (n=195)    69.8±12.4 (n=186)
Systolic blood pressure, mm Hg, mean±SD 116.6±16.0 (n=195) 117.1±17.0 (n=186)
Diastolic blood pressure, mm Hg, mean±SD    71.0±11.2 (n=195)    70.8±12.1 (n=186)
Serum creatinine, mg/dL, mean±SD     1.0±0.2  (n=191)     1.0±0.2  (n=184)
Creatinine clearance, mL/min, mean±SD    83.1±19.8 (n=191)    82.3±21.4 (n=184)

PVD indicates peripheral vascular disease; CHF, congestive heart failure.

*

P=0.03,

P=0.01.